Biosimilar Action Plan (BAP)

On , in Documents, Industry News, by AQ-IQ LLC

Read the FDA’s Action Plan here Excerpts from the plan:  Generic drugs, for instance, represent 90 percent of all prescriptions in the U.S.1 Generic competition facilitated by the 1984 Hatch Waxman Act provided savings of more than $1 trillion to the U.S. health care system over a decade and generated $265 billion in savings in […]